This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

NSTEMI v1.0

  • Research type

    Research Study

  • Full title

    Non-ST-segment elevation myocardial infarction Registry

  • IRAS ID

    261605

  • Contact name

    Chris P. Gale

  • Contact email

    c.p.gale@leeds.ac.uk

  • Sponsor organisation

    European Society of Cardiology

  • Duration of Study in the UK

    1 years, 0 months, 1 days

  • Research summary

    Non-ST-segment elevation myocardial infarction (NSTEMI) is a global health and economic burden. NSTEMI is a leading cause of emergency hospitalisation. The incidence of NSTEMI, is increasing with the ageing and co-morbid population. Moreover, the burden and variation of NSTEMI care and outcomes persists despite substantial improvements in its treatment.
    It is an international, prospective, longitudinal, multi-centre, international observational study to improve the clinical outcomes of patients hospitalised with NSTEMI, through the identification and reporting of sub-optimal delivery of guideline- indicated care. The study is sponsored by the ESC. Data will be collected from patient source document (patient chart) after patient's consent to do so.
    The registry population will comprise consecutive in-patients with ST-segment elevation myocardial infarction presenting in participating countries.
    During a 2 weeks recruitment period, each participating centre will consecutively enrolled all consenting patients who meet the eligibility criteria, without any limit to the maximum number of patients included.
    A 30-days follow-up assessment will be made based on patient-chart, or remotely by phone or during a patient visit.

  • REC name

    HSC REC A

  • REC reference

    19/NI/0122

  • Date of REC Opinion

    18 Jun 2019

  • REC opinion

    Further Information Favourable Opinion